The companies were ranked on customer satisfaction, employee engagement and development, innovation, social responsibility and financial strength. Each organization received a score of zero to 100 in each of the five dimensions.
For the financial strength category, companies were assessed on the following seven metrics of financial performance: return on assets, return on equity, return on invested capital, market share, profits, shareholder return, and economic spread. For companies that made this year’s list of the 250 most effectively managed companies, scores in the financial strength category ranged from 99.5 down to 23.7.
Of the more than 20 U.S.-based healthcare companies that made this year’s top 250 list, here are the 10 that scored the highest in the financial strength category.
1. Gilead Sciences (Foster City, Calif.) — 75.8 financial strength score
2. AbbVie — (North Chicago, Ill.) — 70.5
3. Johnson & Johnson (New Brunswick, N.J.) — 70.4
4. McKesson (San Francisco) — 65.6
5. Amgen (Thousand Oaks, Calif.) — 59.6
6. Regeneron Pharmaceuticals (Tarrytown, N.Y.) — 59
7. Biogen (Cambridge, Mass.) — 58.7
8. Bristol-Myers Squibb (New York City) — 58.1
9. CVS Health (Woonsocket, R.I.) — 57.7
10. Pfizer (New York City) — 57.3
More articles on healthcare finance:
Why HCA will fare better than Tenet and CHS under the GOP tax plan
8 health systems with strong finances
HCA lets major shareholders nominate directors after activist investor pushes for change
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
